Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Lung volumes differentiate the predominance of emphysema versus airway disease phenotype in early COPD

S Zeng, R Bowler, G Luo, D Lynch, M Arjomandi
European Respiratory Journal 2022 60: 4674; DOI: 10.1183/13993003.congress-2022.4674
S Zeng
1University of California San Francisco, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Bowler
2National Jewish Health, Denver, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G Luo
3University of Washington Seattle, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D Lynch
2National Jewish Health, Denver, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Arjomandi
1University of California San Francisco, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

Rationale: Lung volumes identify the “susceptible smokers” who progress to develop spirometric COPD, which seems to be a heterogenous process with staggered onset of different pathologic mechanisms in early disease.

Objective: Determine the radiographic patterns of emphysema and airway disease among susceptible smokers.

Methods: We categorized smokers with preserved spirometry (GOLD-0) in the COPDGene cohort (N=2,159) based on tertiles (low, intermediate, and high) of baseline lung volumes (TLC, FRC, or FRC/TLC), and examined the differential patterns of change in spirometry and the associated prevalence of CT-measured emphysema (Insp-950; PRMEmphysema) and airway disease (EXP-856; PRMAir Trapping; Pi10).

Results: The pattern of spirometric change differed when participants were categorized by TLC versus FRC/TLC: those in high TLC tertile showed stable FEV1 but enlarging FVC while those in high FRC/TLC tertile showed decline in both FEV1 and FVC. Compared to those with high TLC, those with high FRC/TLC had lesser emphysema but greater air trapping, more respiratory symptoms, more decline in physical activity, higher likelihood of progressing to more severe spirometric disease, and a trend towards more severe exacerbations.

Discussion: Lung volumes identify distinct phenotypes in early disease among susceptible smokers and predict the rate of spirometric disease progression and the severity of symptoms in early COPD.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
  • COPD - mechanism
  • Smoking
  • Spirometry

Footnotes

Cite this article as Eur Respir J 2022; 60: Suppl. 66, 4674.

This article was presented at the 2022 ERS International Congress, in session “-”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2022
Previous
Back to top
Vol 60 Issue suppl 66 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lung volumes differentiate the predominance of emphysema versus airway disease phenotype in early COPD
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Lung volumes differentiate the predominance of emphysema versus airway disease phenotype in early COPD
S Zeng, R Bowler, G Luo, D Lynch, M Arjomandi
European Respiratory Journal Sep 2022, 60 (suppl 66) 4674; DOI: 10.1183/13993003.congress-2022.4674

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Lung volumes differentiate the predominance of emphysema versus airway disease phenotype in early COPD
S Zeng, R Bowler, G Luo, D Lynch, M Arjomandi
European Respiratory Journal Sep 2022, 60 (suppl 66) 4674; DOI: 10.1183/13993003.congress-2022.4674
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Diagnostic potential of forced oscillometry technique in adults with normal spirometry: data from the LEAD general population cohort
  • VO2 prediction based on physiologic and mechanical exercise measurements
  • Long-term durability of ivacaftor (IVA) treatment benefit in people with cystic fibrosis (PwCF)
Show more 01.05 - Clinical respiratory physiology, exercise and functional imaging

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society